CureAge Therapeutics
PrivateLast Round
Grant
Jul 16, 2026
Total Funding Raised
$670,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CureAge Therapeutics is a biotechnology company that develops genetic therapies using lipid nanoparticle delivery systems to treat neurofibromatosis type 1 and other peripheral nerve disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CureAge Therapeutics Comparables
Compare CureAge Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rubedo Life Sciences | 84% | |
| Turn Biotechnologies | 79% | |
| Retro Biosciences | 76% | |
CureAge Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 16, 2026 | ||||
| Pre Seed | Jan 1, 2025 |
Key People
Founding team and executive leadership
CureAge Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Science Ventures | Grant, Pre Seed |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Grew 100% QoQ from 3 to 6 employees.
- Jul 16, 2026
$670K raised from Deep Science Ventures and others.
CureAge Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CureAge Therapeutics's valuation, stock price, and market status.